How it works

Trade the catalysts

You're a biotech portfolio manager trading stocks around clinical catalysts — trial readouts, FDA decisions — where the market may have the odds wrong.

For each catalyst, your analyst gives you the estimated edge. Your job is to find the best way to trade that edge.

Start with a single name to learn the ropes, then run a full fund of 12 names.

Your goal is to beat Citadellenium, a deep-pocketed quant pod shop playing the same catalysts.

Navigate the Catalyst Maze

Day 0

PAUSED

The price chart runs in real time once you start. Buy and sell with the controls below the chart. Take a second to get your bearings, then start the clock.

Position size

10% 25% 50% Max

price (quoted) catalyst date your edge

Review your trade

You vs. the pod shop

Portfolio mode

Run the fund

You've got $100M and 20 names to size, one at a time. Before each, decide how much to commit — that capital locks into the name for the rest of the game; whatever you don't commit stays in cash and carries.

Every name has a bullish edge of some size — fat pitches, marginal ones, and no-edge passes where the market's already right. Your job is to size and time the trades to optimize your edge.

Commit to this name $0

Quarterly review

Q1 review

Your fund vs. Citadellenium

Name by name

How the simulation works

How Citadellenium sized & timed

Model real catalysts →